Activest Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Activest Wealth Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Hold	2,000	–	–	﹤0.01%	444
2026 Q1	$19K	Hold	2,000	–	–	﹤0.01%	534
2025 Q4	$15.6K	Hold	2,000	–	–	﹤0.01%	570
2025 Q3	$15.2K	Hold	2,000	–	–	﹤0.01%	423
2025 Q2	$17.9K	Hold	2,000	–	–	﹤0.01%	344
2025 Q1	$15K	Hold	2,000	–	–	﹤0.01%	332
2024 Q4	$15K	Hold	2,000	–	–	﹤0.01%	277
2024 Q3	$15.2K	Hold	2,000	–	–	﹤0.01%	280
2024 Q2	$12.4K	Buy	+2,000	New	+$11K	﹤0.01%	287

Other funds holding BCRX

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

QFW

QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Activest Wealth Management's BCRX Position: Q2 2026 in Review

Activest Wealth Management held its BioCryst Pharmaceuticals (BCRX) position steady in Q2 2026 at 2,000 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Activest Wealth Management first reported a position in BCRX in Q2 2024 and has held it in 9 quarters since. 59 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

Activest Wealth Management held 2,000 shares of BioCryst Pharmaceuticals worth $20K as of Q2 2026.
Activest Wealth Management left its BioCryst Pharmaceuticals share count unchanged in Q2 2026.
BioCryst Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #444 holding.
Activest Wealth Management first reported a position in BioCryst Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
59 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.